Fulgent Genetics

FLGTNasdaq United States Health Care Medical Specialities

Market cap

$592.679 M

$21.54 -0.69%

Close of 21 Sept 2026

Revenue

$322.7M

#2101 by revenue

Earnings

-$60.5M

Loss-making

Shares outstanding

27,515,293

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical Specialities, ranked by market cap

All 44 →

#29Castle BiosciencesCSTL$1.07B
#30Lumexa ImagingLMRI$1.03B
#31Fulgent GeneticsFLGT$592.7M
#32TriSalus Life SciencesTLSI$306.6M
#33BiodesixBDSX$300.0M

What if Fulgent Genetics were worth as much as…

Open the what-if tool →

Gold $30.3T

$1,100,263

Per share 51,080× higher

Bitcoin $1.72T

$62,503.56

Per share 2,902× higher

Nvidia $5.48T

$199,156.81

Per share 9,246× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Fulgent Genetics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.